Researcher Profiles

Return to member profile

Seena C. Aisner, MD

Publications since 2011

Thunnissen, E. Noguchi, M. Aisner, S. Beasley, M. B. Brambilla, E. Chirieac, L. R. Chung, J. H. Dacic, S. Geisinger, K. R. Hirsch, F. R. Ishikawa, Y. Kerr, K. M. Lantejoul, S. Matsuno, Y. Minami, Y. Moreira, A. L. Pelosi, G. Petersen, I. Roggli, V. Travis, W. D. Wistuba, I. Yatabe, Y. Dziadziuszko, R. Witte, B. Tsao, M. S. Nicholson, A. G. Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study. J Thorac Oncol, 9:1354-1362, . (PMID: 25122431)

Pillai, R. N. Aisner, J. Dahlberg, S. E. Rogers, J. S. DiPaola, R. S. Aisner, S. Ramalingam, S. S. Schiller, J. H. Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). Cancer Chemother Pharmacol, 74:177-183, . (PMID: 24858462)

Heller, D. S. Aisner, S. C. Fitzhugh, V. A. Katava, G. Barrett, T. Pseudoangiomatous Stromal Hyperplasia of the Vulva Presenting as a Polypoid Vulvar Lesion: A Lesion Associated With Anogenital Mammary-Like Tissue-Report of a Case and Review of the Literature. J Low Genit Tract Dis, 17:e5-e7, . (PMID: 23609586)

Karp, D. D. Lee, S. J. Keller, S. M. Wright, G. S. Aisner, S. Belinsky, S. A. Johnson, D. H. Johnston, M. R. Goodman, G. Clamon, G. Okawara, G. Marks, R. Frechette, E. McCaskill-Stevens, W. Lippman, S. M. Ruckdeschel, J. Khuri, F. R. Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non-Small-Cell Lung Cancer: ECOG 5597. J Clin Oncol, In process, . (PMID: 24002495)

Guo, J. Y. Karsli-Uzunbas, G. Mathew, R. Aisner, S. C. Kamphorst, J. J. Strohecker, A. M. Chen, G. Price, S. Lu, W. Teng, X. Snyder, E. Santanam, U. Dipaola, R. S. Jacks, T. Rabinowitz, J. D. White, E. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev, 27:1447-1461, . (PMID: 23824538, PMCID: PMC3713426)

Huang, H. F. Shu, P. Murphy, T. F. Aisner, S. Fitzhugh, V. Jordan, M. L. Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer. Mol Cancer Res, In process, . (PMID: 23364535)

Mehta, M. S. Dolfi, S. C. Bronfenbrener, R. Bilal, E. Chen, C. Moore, D. Lin, Y. Rahim, H. Aisner, S. Kersellius, R. D. Teh, J. Chen, S. Toppmeyer, D. L. Medina, D. J. Ganesan, S. Vazquez, A. Hirshfield, K. M. Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One, 8:e69851, . (PMID: 23922822, PMCID: PMC3724883)

Xie, W. Aisner, S. Baredes, S. Sreepada, G. Shah, R. Reiss, M. Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma. Head Neck, In process, . (PMID: 22275186)

Lemma, G. L. Lee, J. W. Aisner, S. C. Langer, C. J. Tester, W. J. Johnson, D. H. Loehrer, P. J. Sr Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma. J Clin Oncol, 29:2060-2065, . (PMID: 21502559, PMCID: PMC3107762)

Ramalingam, S. S. Lee, J. W. Belani, C. P. Aisner, S. C. Kolesar, J. Howe, C. Velasco, M. R. Schiller, J. H. Cetuximab for the Treatment of Advanced Bronchioloalveolar Carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504). J Clin Oncol, 29:1709-1714, . (PMID: 21422434, PMCID: PMC3107763)